Handbook of neurologic rating scales

書誌事項

Handbook of neurologic rating scales

edited by Robert M. Herndon

Demos Medical Pub., c2006

2nd ed

大学図書館所蔵 件 / 2

この図書・雑誌をさがす

注記

Includes bibliographical references and index

内容説明・目次

内容説明

Rating scales are used daily by everyone involved in the management of patients with Neurologic Disease and in the design and management of neurologic clinical trials. Now there is a single source for the wide range of scales used in specific Neurologic Diseases and neurorehabilitation. You will refer to this volume constantly! The first edition of the Handbook of Neurologic Rating Scales quickly became an invaluable reference work on the increasing array of scales for measuring Neurologic Disease. In the brief few years since the first edition the importance of this book has only increased. New chapters include scales on: Generic and general use Pediatric neurology and rehabilitation Peripheral neuropathy and pain Ataxia HIV/AIDS And instruments for diagnosing headaches Formal measurement of the effects of Neurologic Disease and of treatment effects, beyond the description of changes on the standard neurologic examination, is a relatively recent development. Controlled clinical trials and outcomes research are at the heart of modern information-based medicine and neurologic scales are essential tools in clinical trials designed to provide this information. The Handbook of Neurologic Rating Scales provides a resource for Clinicians and Clinical Investigators in the broad field of neurology and neurologic rehabilitation to help them: Evaluate the clinical trials literature by providing information on the scales being used Evaluate and select appropriate and efficient scales for clinical trials and outcomes research Provide information that will help them to develop new scales or measures or to improve existing ones Outcomes research is playing an increasingly important role in clinical management and neurorehabilitation and these also depend largely on measurement of disease status and change. In this era of managed care, Neurologists must produce outcomes data demonstrating the effectiveness of neurologic care if the specialty is to survive and certainly if it is to thrive. Even effective therapies are likely to fall by the wayside if studies to prove their effectiveness are not done. Each chapter in this volume contains the scales of importance and in current use, including a sequence of scale descriptions and specific scales in a standard format, as well as a summary and recommendations indicating which scales are most useful for specific purposes and whether a combination of scales is particularly useful or if better scales are needed. Each entry notes: The purpose for which the scale was developed and its current uses if they differ from those for which it was developed A detailed description of the scale Information about validation, such as: Does the scale have face validity? i.e. does it appear to measure what it purports to measure? How and by whom the scale is administered The time needed to administer and score the scale The scale itself or, when the scale is proprietary or too long for inclusion, a description and key references Special considerations, including unusual measures needed to obtain a valid score or problems in administering the test in specific patients Advantages, or what makes the scale good or useful. Disadvantages, or what makes the scale difficult to use or impairs its reliability Key references, including the original publication of the scale and its validation

目次

  • Introduction to Clinical Neurologic Scales
  • Generic and General Use Scales
  • Pediatric Developmental Scales
  • Pediatric Neurologic & Rehabilitation Rating Scales
  • Amyotrophic Lateral Sclerosis Clinimetric Scales
  • Scales for the Assessment of Movement Disorders
  • Multiple Sclerosis and Demyelinating Diseases
  • Assessment of the Elderly with Dementia
  • Clinical Stroke Scales
  • Peripheral Neuropathy and Pain Scales
  • Diagnostic Headache Criteria and Instruments
  • Scales for Assessment of Ataxia
  • Assessment of Traumatic Brain Injury
  • Health-Related Quality of Life Scales for Epilepsy
  • Rehabilitation Outcome Measures
  • HIV-Associated Cognitive Impairment
  • Conclusions.

「Nielsen BookData」 より

詳細情報

ページトップへ